Literature DB >> 9137550

Molecular characterization of NMDA and metabotropic glutamate receptors.

M Masu1, Y Nakajima, K Moriyoshi, T Ishii, C Akazawa, S Nakanashi.   

Abstract

Our molecular studies have revealed the existence of a large number of different subunits or subtypes for the NMDA and metabotropic glutamate receptors. The individual receptors show functional variabilities and distinct expression patterns in the CNS. The NMDA receptors belong to the ligand-gated ion channel family and consist of a key subunit NMDAR1 and four accessory subunits NMDAR2A-NMDAR2D. The combination of NMDAR1 and NMDAR2 in heteromeric configurations potentiates glutamate response and produces a functional variability. All the NMDAR subunits have an asparagine residue at the corresponding position of the second transmembrane segments, and these residues are thought to be responsible for controlling Ca2+ permeation and the channel blockade by Mg2+ and cationic channel blockers. Individual NMDAR subunit mRNAs are different in their expression patterns during development and in the adult brain. The mGluR family consists of at least six different subtypes. These subtypes are divided into three subgroups according to their sequence similarities, signal transduction mechanisms, and pharmacological properties. Although their physiological roles largely remain to be elucidated, the retinal L-AP4-sensitive mGluR may have a specific function that mediates excitatory neurotransmission in the visual system. It is thus undoubtedly important to investigate specific functions of different combinations of the NMDA receptor subunits and different subtypes of mGluRs and to explore the molecular mechanisms of glutamate receptor-mediated neuronal plasticity and neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 9137550     DOI: 10.1111/j.1749-6632.1993.tb38050.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

1.  Substance P receptor blocker, aprepitant, inhibited cutaneous and other neurogenic inflammation side effects of the EGFR1-TKI, erlotinib.

Authors:  Joanna J Chmielinska; Jay H Kramer; I-Tong Mak; Christopher F Spurney; William B Weglicki
Journal:  Mol Cell Biochem       Date:  2019-12-18       Impact factor: 3.396

2.  Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice.

Authors:  Hyun-Woo Kim; Young-Bae Kwon; Dae-Hyun Roh; Seo-Yeon Yoon; Ho-Jae Han; Kee-Won Kim; Alvin J Beitz; Jang-Hern Lee
Journal:  Br J Pharmacol       Date:  2006-05-08       Impact factor: 8.739

3.  EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade.

Authors:  I Tong Mak; Jay H Kramer; Joanna J Chmielinska; Christopher F Spurney; William B Weglicki
Journal:  J Cardiovasc Pharmacol       Date:  2015-01       Impact factor: 3.105

Review 4.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

5.  Structure-activity relationships for a series of phenylglycine derivatives acting at metabotropic glutamate receptors (mGluRs).

Authors:  J S Bedingfield; M C Kemp; D E Jane; H W Tse; P J Roberts; J C Watkins
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

6.  Molecular mechanisms of group I metabotropic glutamate receptor mediated LTP and LTD in basolateral amygdala in vitro.

Authors:  A Chen; W W Hu; X L Jiang; M Potegal; H Li
Journal:  Psychopharmacology (Berl)       Date:  2016-12-28       Impact factor: 4.530

7.  Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizolcipine.

Authors:  A V Ferrer-Montiel; W Sun; M Montal
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Superoxide and Nitric Oxide Involvement in Enhancing of N-methyl-D-aspartate Receptor-Mediated Central Sensitization in the Chronic Post-ischemia Pain Model.

Authors:  Tae Ha Ryu; Kyung Young Jung; Mi Jin Ha; Kyung Hwa Kwak; Dong Gun Lim; Jung Gil Hong
Journal:  Korean J Pain       Date:  2010-03-10

9.  NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback.

Authors:  Zhihao Mao; Shengxi He; Christopher Mesnard; Paul Synowicki; Yuning Zhang; Lucy Chung; Alex I Wiesman; Tony W Wilson; Daniel T Monaghan
Journal:  Brain Res       Date:  2019-11-28       Impact factor: 3.252

10.  Endogenous PI3K/Akt and NMDAR act independently in the regulation of CREB activity in lumbosacral spinal cord in cystitis.

Authors:  Jarren C Kay; Chun-Mei Xia; Miao Liu; Shanwei Shen; Sharon J Yu; Chulwon Chung; Li-Ya Qiao
Journal:  Exp Neurol       Date:  2013-10-30       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.